CTNM - CIK 0001855175
Contineum Therapeutics, Inc. (CTNM) reported revenue of $0.00 for fiscal year 2024, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2024 | $0.00 | -100.0% |
| FY 2023 | $50.00M | - |
Contineum Therapeutics, Inc. (CTNM) reported revenue of $0.00 for fiscal year 2024, as filed in its audited annual report with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.